Accelmed is a venture capital firm that funds private and public medical device companies with market potential and proven clinical data.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources. Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 25, 2022
Diagnostic Robotics
|
Series B | $45M | Artificial Intelligence | — |
May 18, 2022
Veranex
|
Private Equity(PE) | — | Health Care | — |
Oct 22, 2021
Click Therapeutics
|
Series B | $52M | Biotechnology | Yes |
Feb 20, 2020
Liquid Death
|
Series A | $9M | Food and Beverage | — |
Jan 30, 2020
Haus
|
Seed | $4.50M | Distillery | — |